STOP GARDASIL AND CERVARIX, HPV, HUMAN PAPILLOMA VIRUS, AFTER VACCINES./ DETENGAN LAS VACUNAS CONTRA EL VPH

 

 

 

HPV, Human Papilloma Virus, After Vaccines. !

 

VPH, Virus del Papiloma Humano despues de las Vacunas. ! 

 
EDITORIAL ENGLISH

===================

Hello friends of the network, as I promised, today the DERMAGIC EXPRESS brings you the HPV edition, HUMAN PAPILLOMA VIRUS, AFTER THE VACCINES. As I explained to everyone in the last issue, HPV has spread throughout the world since it was discovered and continues its dissemination process in spite of social preventive campaigns and the INVESTIGATION OF VACCINES to avoid contagion.

That is the topic today, but first I will tell you that it was in year 1.978 when the HPV 5 subtype associated with SKIN CANCER was discovered for the first time, later in 1.981 and 1.984 the association of HPV subtypes 16 and 18 was discovered To CERVICAL CANCER in women.

Despite these discoveries, HPV continued to spread throughout the world and that is when scientists INVENTED 3 VACCINES: CERVARIX AND GARDASIL 4 AND 9 to prevent infection ... and here I will put you objectively what happened with these VACCINES and subsequently , I will give my opinion as a medical dermatologist with more than 20 years in this world of research on DERMATOLOGICAL AND NON-DERMATOLOGICAL MEDICINES.

But first let's talk a little about these VACCINES:

GARDASIL (QUADRIVALENT, HPV4), ALSO KNOWN AS SILGARD:
========================================================

1.) WAS THE FIRST FDA APPROVED VACCINE TO PREVENT HPV IN JUNE 8, 2006, AGAINST 4 TYPES OF HPV.
2.) PROTECTS AGAINST TYPES: 16, 18, (ONCOGENIC), 6 AND 11 (LOW RISK).
3.) TO BE USED IN MEN AND WOMEN BETWEEN 9 AND 26 YEARS.
4.) COMPOSED BY L1 PROTEINS OF THE DESCRIBED HPV.
5.) ADJUVANTS: ALUMBER, POLYSORBATE 80, SODIUM BORATE, L HISTIDINE AND SODIUM CHLORIDE.
6.) ADMINISTRATION: INTRAMUSCULAR: 3 DOSES, TO 0, 2 AND 6 MONTHS.
7.) LABORATORY: MERCK SAHRP & DOHME (MSD)

CERVARIX (BIVALENT HPV2):
=========================

1.) APPROVED BY THE FDA IN OCTOBER 2.009, BECOMING THE SECOND APPROVED VACCINE TO PREVENT HPV.
2.) PROTECTS AGAINST TYPES OF HPV: 16 AND 18 (ONCOGENIC).
3.) TO BE USED IN WOMEN BETWEEN 9 AND 25 YEARS.
4.) NOT APPROVED FOR USE IN MEN.
5.) COMPOSED BY L1 PROTEINS OF THE DESCRIBED HPV.
6.) ADJUVANTS: SODIUM CHLORIDE (NACl), DIHYDROGEN SODIUM DIHYDRATE PHOSPHATE(NaH2PO4.2 H2O), DISTILLED WATER.
7.) ADMINISTRATION: INTRAMUSCULAR: 3 DOSES OF 0.5 ML, AT 0, 1 AND 6 MONTHS.
8.) LABORATORY: GLAXOSMITHKLINE (GSK)

GARDASIL 9 (VALENTE):
=====================
 
1.) APPROVED BY THE FDA ON DECEMBER 10, 2014 TO PREVENt AGAINST 9 TYPES OF HPV.
2.) PROTECTS AGAINST HPV TYPES: 16, 18, 31, 33, 45, 52, and 58 (ONCOGENICS), 6 AND 11 (LOW RISK).
3.) TO BE USED IN WOMEN BETWEEN 9 AND 26 YEARS AND MEN BETWEEN 9 AND 15 YEARS.
4.) PREVENTS 90% OF THE CANCER OF THE UTERINE NECK.
5.) EXCEED THE PREVIOUS VERSION GARDASIL 4, WHICH PROTECTS ONLY AGAINST 4 TYPES OF HPV.
6.) COMPONENTS: L1 PROTEINS OF THE HPV VIRUS BEFORE DESCRIBED.
7.) ADJUVANT: ASO4: AMORF ALUMINUM SULPHATE HYDROXYPHOSPHATE.
8.) ADMINISTRATION: INTRAMUSCULAR: 3 DOSES OF 0.5 ML, TO 0, 2-6, 6-12 MONTHS.
9.) LABORATORY: MERCK SHARP & DOHME. (MSD) and SANOFI PASTEUR

Obviously there are more LABORATORIES INVOLVED, which commercialized the VACCINES. But the ORIGINAL authors were: GARDASIL: MERCK SHARP & DOHME (MS), AND CERVARIX: GLAXOSMITHLINE (GSK)

As you will be able to observe APARENTLY, they were WONDERFUL inventions, the population thought that, soon they would be free of the dreaded HPV, mainly the ONCOGENICS, and in addition you could have SEX WITHOUT PROTECTION and you would not be contagious by those HPV STRAINS described in these vaccines, BUT THE REALITY WAS ANOTHER. !!

SUMMARIZING:
=============

PROTECTION OF VACCINES COVERS HPV TYPES: 16, 18, 31, 33, 45, 52, 58 (ONCOGENIC), AND 6 AND 11 LOW RISK (GENITAL WARTS), IN TOTAL 9 TYPES, as the original GARDASIL and The CERVARIX include types 16, 18 and 6, 11 INCLUDED in the GARDASIL 9.

Before proceeding, let us make the following reflection: HOW MANY TYPES OF HPV exist that infect the genital mucosa? Let's take a look at the PRE-EDITION OF DERMAGIC EXPRESS: HPV, HUMAN PAPILLOMA VIRUS, BEFORE VACCINES

"... For Today, 2,017 there are approximately 120 types of HPV, of which 51 species affect the genital mucosa being the most carcinogenic types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56 , 58, 59, 68, 73 and 82. Of probable high risk : 26, 53, and 66, and of low carcinogenic risk: 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and 108 .... "

CARCINOGENICS ARE 15 TYPES OF HPV, THOSE THAT ARE PROBABLE HIGH RISK 3, AND THOSE OF LOW RISK: 12,
 ==============================================================================

THE VACCINES DESCRIBED: PROTECT AGAINST:

1.) ONLY 7 TYPES OF HPV OF THE 15 DESCRIBED AS ONCOGENICS. LESS THAN 50%.
 2.) DO NOT PROTECT FROM PROBABLE HPV HIGH RISK: 0%.
 3.) PROTECT ONLY 2 TYPES OF LOW-RISK HPV FROM THE 12 DESCRIBED: 16%

However the FDA approved these VACCINES and were sold AS "MAIZE GRAINS" being implemented in more than 120 countries. Big profits for the laboratories described above.

The majority of the studies said that they were SAFE and as only great adverse effect it was PAIN IN THE SITE OF INJECTION and in rare occasions SINCOPE. Did you read well ?

But the reality was another, SEVERE ADVERSE EFFECTS AND EVEN DEATHS after the VACCINATION began. Becoming a TRAGEDY for parents and relatives of GIRLS and CHILDREN who died or developed SEVERE ADEVERSE EFFECTS. At the level of all the WORLD were presented these cases, being the most affected JAPAN, DENMARK, IRELAND, COLOMBIA, SWEDEN, NEW ZEALAND, SPAIN, INDIA, CANADA, and UNITED STATES. Did you read well? WORLDWIDE.

In European countries (SWEDEN) began to call the set of signs and symptoms produced post vaccination of GARDSIL, with the name POST GARDSASIL SYNDROME (PGS), in other countries began to call them THE "MURDER'S" VACCINES (CHILE) in other PARALYZING DISEASE ( NEW ZEALAND).

"... In SPAIN, the situation became hotter and Merck-Sanofi Pasteur received from the national and regional sanitary authorities (La Rioja) of Spain, charges or penalty for:

"... Fraudulent marketing and / or administration of an inadequately proven vaccine.
 Do not inform the public about the potential risks of the use of Gardasil ... and others, being the most EMBLEMATIC case a GIRL called ZURIÑE of 18 years of age who suffered DEMINERALIZATION of its body putting her in a state of a person OF 60 YEARS. .. "

IN JAPAN: "... A total of 98 girls who developed health problems requested assistance from 2.011 to 2.014. Of the 90% vaccinated, 186 of the girls did not recover from these events ....
A Japanese EXPERT asked that the VACCINE BE REMOVED FROM THE MARKET because of its HARMFUL effects ... and a DEMAND was raised for 140 million DOLLARS for the damages caused to the population by the vaccines against HPV "

In COLOMBIA, many teenagers fainted within a few hours of VACCINATION. And there are girls who DO NOT RECOVER of the ADVERSE EFFECTS, being the first victim publicly known the girl MARIA PAULA MEJIA. MAY 6, 2.014, AND CARMEN BOLIVAR.

IN IRELAND 130 GIRLS became ill after the VACCINATION against HPV ... which caused a scandal.

IN INDIA ... THE FIRST GARDASIL VACCINE caused several DEATHS at the beginning of 2.009 and the GOVERNMENT ordered the suspension of all HPV VACCINE TRIALS, which is still in effect today. In 2.013 the Supreme Court admitted the petition and accused Merck and GlaxoSmithKline of "CHILD ABUSE" for creating marketing with these VACCINES.

IN CANADA, an article was published WHERE THE ADJUVANT ALUMINUM AND ANTIGENS OF HPV HAVE THE ABILITY TO RELEASE NEUROINFLAMATION AND AUTOIMMUNE REACTIONS, leading to future changes in behavior in susceptible people ... "

IN THE UNITED STATES ... "Up to January 31, 2.010, 49 unexplained deaths were reported after GARDASIL injections by CDC (Centers for Disease Control and Prevention) and VAERS (Vaccine Adverse Event Reporting System ) ...

For July of 2,015 the EMA (EUROPEAN AGENCY OF MEDICINS) reports 311 deaths BY GARDASIL and 41 by CERVARIX ...

Even after ALL these data, that are a summary: THE VACCINES ARE STILL IN THE MARKET.

I WILL NOW PUT YOU THE LIST OF ADVERSE EFFECTS ASSOCIATED WITH THESE VACCINES:
 ==========================================================================
 
1.) SUDDEN DEATH , IN SOME CASES HOURS AFTER THE INJECTION.

2.) ASIA SYNDROME: AUTOINMUNE AND INFLAMMATORY SYNDROME INDUCED BY THE ADJUVANTS OF VACCINES FOR HPV. THE CHARACTERISTICS OF THIS SYNDROME ARE:

A-) PYREXIA (58%).
B-) MYALGIA (27%)
C-) ARTHRITIS OR ARTHRALGIA (19%)

3.) OPTICAL NEURITIS. (Some consider this inconclusive).
4.) VENOUS THROMBOEMBOLISM (VTE)
5.) PAIN IN THE ARM (SITE OF THE INJECTION).
6.) CHRONIC FATIGUE SYNDROME. (CFS).
7.) POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME (POTS).
8.) CHRONIC REGIONAL PAIN SYNDROME (CRPS).
9.) DIZZINESS.
10.) PSYCHOSOMATIC REACTION.
11.) MUSCLE WEAKNES.
12.) BLEEDING FROM NOSE AND GUMS.
13.) PAIN IN THE KNESS AND ANKLE.
14.) VOMITING.
15.) DIARRHEA.
16.) BONE PAIN.
17.) MIGRAINES.
18.) NECK PAIN.
19.) TINGLING.
20.) ELECTRICAL "ZAPS" HIPS AND BACK.
21.) INSOMNIA.
22.) WRIST PAIN.
23.) FAINTING
24.) LOST CONSCIOUSNESS.
25.) CONVULSIONS
26.) PALE.
27.) HANDS AND FEETS FEEL COLD.
28.) FATIGUE.
29.) PALPITATIONS.
30.) SWEATING
31.) STIMULATION OF AUTO-IMMUNITY BY THE ALUMINUM CONTENT OF THE VACCINE, (GARDASIL) WHICH CAN TRIGGER: MUSCLE SPASM, PAIN, IRRITABILITY, ARRHYTMIAS, HEADACHES, BRITTLE BONES, INFLAMMATION, AUTO-INMMUNE REACTIONS AND MORE.


I guess you're waiting for MY OPINION on this ... and I'll give it to you STEP BY STEP:
================================================================

1.) INVENTED VACCINES ONLY PROTECT AGAINST LESS THAN 50% OF THE ONCOGENIC TYPES OF HPV DESCRIBED. THEREFORE, THEY DO NOT HAVE SCIENTIFIC JUSTIFICATION FROM THE POINT OF VIEW OF THE PREVENTION.

2.) THE FACT THAT THE HPV TYPES 16, 18, 31, 33, 45, 52, AND 58, THE MOST COMMON AND ONCOGENIC, ARE INCLUDED IN THE VACCINES, DOES NOT RELEASE YOU OF THE CERVICAL CANCER, FOR THE PREVIOUSLY MENTIONED.

2.) THE INVENTION IS BAD IMPLEMENTED, SINCE PROTEINS ARE USED FOR EVERY TYPE OF HPV, THE IDEAL HAVE BEEN A PROTEIN OR "ANTIGEN" COMMON TO ALL TYPES OF HPV.

3.) MIXING THESE ANTIGENS OF EACH TYPE OF HPV IN A SINGLE SOLUTION, SEEMS TO ME LIKE A BIOLOGICAL "BOMB", WHICH HAS PROVOKED DEATH AND THOUSANDS OF AFFECTED EVERYWHERE ON THE PLANET, MANY OF THOSE THAT WERE NOT RECOVERED YET.

4.) USING ALUMINUM AS ADJUVANT IT WAS ANOTHER ERROR, AS IT IS KNOWN THAT THE SAME IS INVOLVED IN INFLAMMATORY AND AUTO-IMMUNE REACTIONS.

5.) THE SEVERE SIDE EFFECTS: CHRONIC FATIGUE SYNDROME. (CSF), ORTOSTATIC POSTURAL TACHYCARDIA SYNDROME. (POTS), CHRONIC SYNDROME OF REGIONAL PAIN ... AND OF COURSE SUDDEN DEATH ... BUT NOT DISCARD ANY OF THE DESCRIBED.

6.) THE VACCINATION CAMPAIGNS WERE BADLY DIRECTED: THE IDEA WAS TELL THAT THESE VACCINES ARE THE "SALVATION OF HUMANITY AGAINST HPV ..."

7.) SERIOUSLY THOUGHT THAT THEY WERE NOT WELL "TESTED" BECAUSE IN MOST OF THE STUDIES THAT YOU FOUND IN THE DATABASES, ALMOST EVERYONE CONCLUDES THAT: THEY ARE SAFE, NOTHING BUT FALSE.

To conclude once again I want to say very responsibly that I HAVE NOTHING ABOUT THE SCIENTIFIC LABORATORIES, who invented these vaccines, for that they are, to create solutions for our diseases. But in this case of VACCINES AGAINST HPV, I also very responsibly say that:

WERE A BIG FAILURE AND WILL CONTINUE TO KILL AND DAMAGING THE HEALTH OF THE POPULATION THAT ACCESSES THESE VACCINES ... so that:

"... IF YOU READ THIS ARTICLE, YOU ARE GIRL OR MAN AND YOU ARE IN THE AGE COMPREHENDED TO ACCESS THESE VACCINES ... DO NOT DO IT ... YOU CAN DIE IN THE ATTEMPT ... OR SICK OF LIFE ..."

And I remember what I said in the PREVIOUS EDITION OF DERMAGIC EXPRESS on HPV BEFORE VACCINES:

 "... By that time, BEFORE THE VACCINES against this disease, HPV DEATH was produced by CANCER, today, AFTER VACCINES for HPV, death is not only by CANCER ... ARE ALSO THE VACCINES ... "

Greetings to all.

Dr. José Lapenta.




EDITORIAL ESPAÑOL 
=================
Hola amigos de la red, como les prometí, hoy el DERMAGIC EXPRESS te trae la edición VPH, VIRUS DEL PAPILOMA HUMANO, DESPUES DE LAS VACUNAS. Como les explique a todos en la edición pasada el VPH se fue extendiendo POR TODO EL MUNDO desde que fue descubierto y sigue su proceso de diseminación a pesar de las campañas preventivas sociales y EL INVENTO DE LAS VACUNAS para evitar el contagio.

Ese es el tema de hoy, pero primeramente te voy a decir que fue en año 1.978 cuando se descubrió por primera vez el subtipo VPH 5 asociado a CANCER DE PIEL, posteriormente en 1.983 y 1.984 se descubrió la asociación de VPH subtipos 16 y 18 asociados a CANCER CERVICAL en la mujer.

A pesar de estos descubrimientos el VPH siguió diseminándose por todo el mundo y entonces fue cuando los científicos INVENTARON 3 VACUNAS: CERVARIX Y GARDASIL 4 Y 9 para prevenir el contagio... y aquí te pondré objetivamente lo que paso con estas VACUNAS y posteriormente te daré mi opinión como medico dermatólogo con más de 20 años metido en este mundo de la investigación de MEDICINAS DERMATOLOGICAS Y NO DERMATOLOGICAS.

Pero primero hablemos un poco de estas VACUNAS:

GARDASIL (CUADRIVALENTE, HPV4), TAMBIEN CONOCIDA COMO SILGARD:
===================================================================

1.) FUE LA PRIMERA VACUNA APROBADA POR LA FDA PARA PREVENIR EL VPH EN JUNIO 8 DE 2.006, CONTRA 4 TIPOS DE VPH
2.) PROTEGE CONTRA LOS TIPOS: 16, 18, 6 Y 11 (ONCOGENICOS Y DE BAJO RIESGO)
3.) PARA SER USADA EN HOMBRES Y MUJERES ENTRE 9 Y 26 AÑOS.
4.) COMPUESTA POR PROTEINAS L1 DE LOS VPH DESCRITOS.
5.) ADYUVANTES: ALUMBRE, POLISORBATO 80, BORATO DE SODIO, L HISTIDINA Y CLORURO DE SODIO.
6.) ADMINISTRACION: INTRAMUSCULAR: 3 DOSIS, A LOS 0, 2 Y 6 MESES.
7.) LABORATORIO: MERCK SAHRP & DOHME (MSD)

CERVARIX (BIVALENTE HPV2):
 =========================
 

1.) APROBADA POR LA FDA EN OCTUBRE DE 2.009, CONVIERTIENDOSE EN LA SEGUNDA VACUNA APROBADA PARA PREVENIR EL VPH.
2.) PROTEGE CONTRA LOS TIPOS DE VPH: 16 Y 18 (ONCOGENICOS).
3.) PARA SER USADA EN MUJERES ENTRE 9 Y 25 AÑOS.
4.) NO FUE APROBADA PARA SER UTILIZADA EN MASCULINOS.
5.) COMPUESTA POR PROTEINAS L1 DE LOS VPH DESCRITOS.
6.) ADYUVANTES: CLORURO DE SODIO (NACl), DIHIDROGENO FOSFATO DE SODIO DIHIDRATO (NaH2PO4.2 H2O), AGUA DESTILADA.
7.) ADMINISTRACION: INTRAMUSCULAR: 3 DOSIS DE 0.5 ML, A LOS 0, 1 Y 6 MESES.
8.) LABORATORIO: GLAXOSMITHKLINE(GSK)

GARDASIL 9 (VALENTE):
 ====================
 

1.) APROBADA POR LA FDA EL 10 DE DICEMBRE DE 2.014 PARA PREVENIR EL CONTAGIO CONTRA 9 TIPOS DE VPH.
2.) PROTEGE CONTRA LOS TIPOS DE VPH: 16, 18, 31, 33, 45, 52, 58 (ONCOGENICOS), 6 Y 11 (BAJO RIESGO).
3.) PARA SER USADA EN MUJERES ENTRE 9 Y 26 AÑOS Y HOMBRES ENTRE 9 Y 15 AÑOS.
4.) PREVIENE CONTRAEL 90% DEL CANCER DE CUELLO UTERINO. (LEAN BIEN 90%)
5.) SUPERA A SU VERSION PREVIA GARDASIL 4, LA CUAL PROTEGE SOLO CONTRA 4 TIPOS DE VPH.
6.) COMPONENTES: PROTEINAS L1 DE LOS VIRUS VPH ANTES DESCRITOS.
7.) ADYUVANTE: ASO4: HIDROXIFOSFATO SULFATO DE ALUMINIO AMORFO.
8.) ADMINISTRACION: INTRAMUSCULAR: 3 DOSIS DE 0.5 ML, A LOS 0, 2-6, 6-12 MESES.
9.) LABORATORIO: MERCK SHARP & DOHME. (MSD) y SANOFI PASTEUR

Obviamente hay mas laboratorios INVOLUCRADOS, que comercializaron las VACUNAS. Pero Los autores ORIGINALES FUERON: GARDASIL: MERCK SHARP & DOHME (MS), Y CERVARIX: GLAXOSMITHLINE (GSK)

Como podrás observar APARENTEMENTE, fueron MARAVILLOSOS inventos, la población pensó que pronto se liberarían del temido VPH, sobre todo los ONCOGENICOS, y además podrías tener SEXO SIN PROTECCION y no te ibas a contagiar por esas CEPAS de VPH descritas en esas vacunas, PERO LA REALIDAD FUE OTRA. !!
 
RESUMIENDO:
============

LA PROTECCION DE LAS VACUNAS CUBRE LOS TIPOS DE VPH: 16, 18, 31, 33, 45, 52, 58 (ONCOGENICOS), Y 6 Y 11 DE BAJO RIESGO (VERRUGAS GENITALES), EN TOTAL 9 TIPOS, pues la GARDASIL original Y la CERVARIX incluyen los tipos 16, 18 Y 6, 11 INCLUIDOS EN LA GARDASIL 9.

Antes de continuar hagamos la siguiente reflexión: CUANTOS TIPOS DE VPH existen que infectan la mucosa genital? Hagamos un recuento de la EDICION PREVIA DEL DERMAGIC EXPRESS: VPH, VIRUS DEL PAPILOMA HUMANO ANTES DE LAS VACUNAS.

"... Para Hoy 2.017 hay aproximadamente 120 tipos de VPH, de los cuales 51 especies afectan la mucosa genital siendo hoy día los mas carcinogénicos son: los tipos 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, y 82. De probable alto riesgo: el 26, 53,y 66, y de bajo riesgo cancerígeno: 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, y 108...."

LOS CARCINOGENICOS SON 15 TIPOS DE VPH, LOS DE PROBABLE ALTO RIESGO 3, Y LOS DE BAJO RIESGO: 12,
=======================================================================
 
LAS VACUNAS DESCRITAS: PROTEGEN CONTRA:
 
1.) SOLO 7 TIPOS DE VPH DE LOS 15 DESCRITOS COMO ONCOGENICOS. MENOS DEL 50%.
2.) NO PROTEGEN CONTRA LOS VPH DE PROBABLE ALTO RIESGO: 0%.
3.) PROTEGEN SOLO CONTRA 2 TIPOS DE VPH DE BAJO RIESGO DE LOS 12 DESCRITOS: 16%

Sin embargo la FDA aprobó estas VACUNAS y se vendieron COMO "GRANOS DE MAIZ" siendo implementadas en más de 120 países. Unas grandes ganancias para los laboratorios antes descritos. 

La mayoría de los estudios decían que eran SEGURAS y como único gran efecto adverso era LEASE BIEN: DOLOR EN EL SITIO DE LA INYECCION y en contadas ocasiones SINCOPE.
 
Pero la realidad fue otra, COMENZARON A APARECER SEVEROS EFECTOS ADVERSOS E INCLUSO MUERTES luego de la VACUNACION. Convirtiéndose en una TRAGEDIA para los padres y familiares de NIÑAS y NIÑOS que murieron o desarrollaron SEVEROS EFECTOS ADVERSOS. 

A nivel de todo el MUNDO se presentaron estos casos, siendo los más afectados­ JAPON, DINAMARCA, IRLANDA, COLOMBIA, SUECIA, NUEVA ZELANDA, ESPAÑA, INDIA, CANADA, y ESTADOS UNIDOS. Leíste bien? EN TODO EL MUNDO.
 
En países Europeos (SUECIA) comenzaron a llamar al conjunto de signos y síntomas producidos post vacunación de GARDSIL, con el nombre de POST GARDSASIL SINDROME (PGS), en otros países comenzaron a llamarlas LAS VACUNAS ASESINAS, (CHILE) en otros ENFERMEDAD PARALIZANTE (NUEVA ZELANDA).

"... En ESPAÑA, la situación se puso más caliente y Merck-Sanofi Pasteur recibió por parte de las autoridades sanitarias nacionales y regionales (La Rioja) de España, cargos o penalización por:
"...Comercialización fraudulenta y / o administración de una vacuna inadecuadamente probada.
No informar al público sobre los riesgos potenciales del uso de Gardasil... y otros mas, siendo el caso más EMBLEMATICO una NIÑA llamada ZURIÑE de 18 años de edad quien sufrió DESMINERALIZACION de su cuerpo poniéndola en un estado de una persona DE 60 AÑOS..."

EN JAPON: " ... Un total de 98 niñas que desarrollaron problemas de salud solicitaron asistencia de 2011 a 2014. Del 90% de vacunados, 186 de las niñas no se recuperaron de estos eventos....
UN EXPERTO japonés pidió que la VACUNA FUERA RETIRADA DEL MERCADO por sus efectos NOCIVOS...y se planteo UNA DEMANDA por 140 millones de DOLARES por los daños ocasionados a la población por las VACUNAS contra VPH"
 
En COLOMBIA muchos adolescentes se desmayaron pocas horas después de VACUNADOS.. Y hay niñas que NO SE RECUPERARON de LOS EFECTOS ADVERSOS, siendo la primera víctima conocida públicamente la niña MARIA PAULA MEJIA. 6 DE MAYO 2014. Y CARMEN BOLIVAR.
 
EN IRLANDA 130 NIÑAS se enfermaron después de la VACUNACION contra VPH... lo cual provoco un escándalo.
 
EN INDIA... la PRIMERA VACUNA GARDASIL provoco varias MUERTES a comienzos del 2.009 y el GOBIERNO ordeno la suspensión de todas las PRUBAS DE LAS VACUNAS CONTRA EL VPH, vigente hasta hoy día. En 2.013 la Suprema Corte admitió la petición y se acuso a Merck y GlaxoSmithKline de "ABUSO INFANTIL" por crear comercialización con estas VACUNAS.
 
EN CANADA se publico un articulo DONDE EL ADYUVANTE ALUMINIO Y LOS ANTIGENOS DEL VPH tienen la habilidad de DESENCADENAR NEUROINFLAMACION Y REACCIONES AUTOINMUNES, llevando a futuros cambios en el comportamiento en personas susceptibles..."
 
EN ESTADOS UNIDOS..." Hasta el 31 de enero de 2010, SE REPORTARON 49 MUERTES inexplicadas después de las inyecciones de GARDASIL por el CDC(Centros para el Control y Prevención de Enfermedades) Y VAERS (Sistema de Notificación de Eventos Adversos de Vacunas)...
 
Para Julio de 2.015 la EMA (AGENCIA EUROPEA DE MEDICAMENTOS) reporta 311 muertes POR GARDASIL y 41 por CERVARIX...
 
Aun después de TODOS ESTOS datos que son un resumen: LAS VACUNAS SIGUEN EN EL MERCADO.
 
AHORA TE VOY A PONER LA LISTA DE EFECTOS ADVERSOS ASOCIADOS A ESTAS VACUNAS:
 ========================================================================
 
1.) MUERTE SUBITA, EN ALGUNOS CASOS HORAS DESPUES DE LA INYECCION.
 
2.) ASIA SINDROME: SINDROME AUTOINMUNE E INFLAMATORIO INDUCIDO POR LOS ADYUVANTES DE LAS VACUNAS PARA EL VPH. LAS CARACTERISTICAS DE ESTE SINDROME SON:
 
A-) PIREXIA.(58%).
B-) MIALGIA (27%)
C-) ARTRALGIA O ARTRITIS (19%)
 
3.) NEURITIS OPTICA. (Algunos consideran esto no concluyente).
4.) TROMBOEMBOLISMO VENOSO.
5.) DOLOR EN EL BRAZO (SITIO DE LA INYECCION).
6.) SINDROME DE FATIGA CRONICO. (CSF).
7.) SINDROME DE TAQUICARDIA POSTURAL ORTOSTAICA. (POTS)
8.) SINDROME CRONICO DE DOLOR REGIONAL.
9.) MAREOS.
10.) REACCION PSICOSOMATICA.
11.) DEBILIDAD MUSCULAR.
12.) SANGRAMIENTO NASAL Y POR LAS ENCIAS.
13.) DOLOR EN LAS RODILLAS Y TOBILLOS.
14.) VOMITOS.
15.) DIARREA.
16.) DOLOR OSEO.
17.) MIGRAÑAS.
18.) DOLOR EN EL CUELLO.
19.) SENSACION DE HORMIGUEO.
20.) SENSACION DE "CORRIENTAZOS" EN CADERAS Y ESPALDA.
21.) INSOMNIO.
22.) DOLOR EN LAS MUÑECAS.
23.) DESMAYO.
24.) PERDIDA DE LA CONCIENCIA.
25.) CONVULSIONES.
26.) PALIDEZ.
27.) ENFRIAMIENTO DE MANOS Y PIES.
28.) FATIGA.
29.) PALPITACIONES.
30.) SUDORACION.
31.) ESTIMULACION DE LA AUTOINMUNIDAD POR EL CONTENIDO DE ALUMINIO DE LA VACUNA, (GARDASIL) EL CUAL PUEDE DETONAR: ESPASMO MUSCULAR, DOLOR, IRRITABILIDAD, ARRITMIAS, DOLORES DE CABEZA, FRAGILIDAD OSEA, INFLAMACION, REACCIONES AUTOINMUNES Y MAS.

Me imagino que estas esperando MI OPINION al respecto... y te la voy a dar PASO POR PASO:
 ===========================================================================
 
1.) LAS VACUNAS INVENTADAS SOLO PROTEGEN CONTRA MENOS DEL 50% DE LOS TIPOS DE VPH CANCERIGENOS DESCRITOS. POR LO TANTO, NO TIENEN JUSTIFICACION CIENTIFICA DESDE EL PUNTO DE VISTA DE LA PREVENCION.
 
2.) EL HECHO DE QUE EN LAS VACUNAS ESTEN INCLUIDOS LOS VPH TIPO 16 Y 18, 31, 33, 45, 52, Y 58, LOS MAS COMUNES Y ONCOGENICOS, NO TE LIBERA DE EL CANCER CERVICAL POR LO ANTES DICHO.
 
2.) EL INVENTO ESTA MAL IMPLEMENTADO, PUES SE UTILIZA PROTEINAS DE CADA TIPO DE VPH, LO IDEAL HUBIESE SIDO UNA PROTEINA O "ANTIGENO" COMUN A TODOS LOS TIPOS DE VPH.
 
3.) MEZCLAR ESTOS ANTIGENOS DE CADA TIPO DE VPH EN UNA SOLA SOLUCION ME PARECE UNA "BOMBA" BIOLOGICA, LA CUAL DESENCADENO MUERTE Y MILES DE AFECTADOS EN TODO EL PLANETA, MUCHOS DE LOS CUALES NO SE RECUPERARON TODAVIA.
 
4.) UTILIZAR ALUMINIO COMO ADYUVANTE FUE OTRO ERROR MAS, PUES ES CONOCIDO QUE EL MISMO ESTA INVOLUCRADO EN REACCCIONES INFLAMATORIAS Y AUTOINMUNES.
 
5.) LOS EFECTOS SECUNDARIOS MAS SEVEROS: SINDROME DE FATIGA CRONICO. (CSF), SINDROME DE TAQUICARDIA POSTURAL ORTOSTAICA. (POTS), SINDROME CRONICO DE DOLOR REGIONAL... Y POR SUPUESTO MUERTE SUBITA... PERO NO SE DESCARTA NINGUNO DE LOS DESCRITOS.
 
6.) LAS CAMPAÑAS DE VACUNACION FUERON MAL DIRIGIDAS: SE VENDIO LA IDEA DE QUE ESTAS VACUNAS ERAN LA "SALVACION DE LA HUMANIDAD CONTRA EL VPH..."
 
7.) PIENSO SERIAMENTE QUE NO FUERON BIEN "PROBADAS" PORQUE EN LA MAYORIA DE LOS ESTUDIOS QUE ENCUENTRAN EN LAS BASES DE DATOS, CASI TODOS CONCLUYEN QUE: SON SEGURAS, NADA MAS FALSO.
 
Para finalizar una vez más quiero decir muy responsablemente que NO TENGO NADA EN CONTRA DE LOS LABORATORIOS CIENTIFICOS, que inventaron estas vacunas, para eso están ellos, para crear soluciones para nuestras enfermedades. Pero en este caso de las VACUNAS CONTRA EL VPH, también muy responsablemente digo que:
 
FUERON UN TREMENDO FRACASO Y SEGUIRAN MATANDO Y ENFERMANDO A LA POBLACION QUE ACCEDA A ESTAS VACUNAS... de modo que:
 
"... SI LEISTE ESTE ARTICULO, ERES NIÑA O VARON Y ESTAS EN LA EDAD COMPRENDIDA PARA ACCEDER A ESTAS VACUNAS... NO LO HAGAS... PUEDES MORIR EN EL INTENTO...O ENFERMARTE DE POR VIDA..."
 
Y te recuerdo lo que dije en la EDICION PREVIA DEL DERMAGIC EXPRESS sobre EL VPH ANTES DE LAS VACUNAS:

"... Para el tiempo aquel, ANTES DE LAS VACUNAS contra esta enfermedad, LA MUERTE POR VPH era producida por el CANCER, hoy día, DESPUES DE LAS VACUNAS para el VPH, la muerte no es solo por el CANCER... SON TAMBIEN LAS VACUNAS..."
 
Saludos a todos.
 
Dr. José Lapenta.
=======================================================================
REFERENCIAS BIBLIOGRAFICAS/ BIBLIOGRAPHICAL REFERENCES
=======================================================================1.) Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
2.) Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials.
3.) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.
3.) Evaluation of optic neuritis following human papillomavirus vaccination.
4.) Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials.
5.) Adverse events following HPV vaccination, Alberta 2006-2014.
6.) Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
6.) The Nordic Cochrane Collaboration
7.) An International Brushfire
8.1.) Japan, HPV Vaccination Controversy in Japan, Rates Plummet to 1%
9.2.) Denmark, TV2 Denmark Documentary on HPV Vaccine Shows Lives of Young Women Ruined
10.3.) Ireland
11.4.) Colombia, MAY 6, 2014 Gardasil Scandal Brewing in Colombia?
12.) Mystery illness plagues girls in Colombia
13.5.) Sweden, Swedish cover-up of HPV vaccine side effects — and more
14.6.) New Zealand Cause or coincidence? (November 2015)
15.7.) Spain, : Spain Joins Growing List of Countries to File Criminal Complaints
16.) Gardasil: Criminal complaint filed in Spain
17.8. ) India HPV, Vaccine Trials in India: Is Merck above the law?
18.) Indian Parliament Comes Down Hard on Cervical Cancer Trial
19.9.) Canada, Canadian study questioning safety of HPV vaccine retracted
20.10. Finally, the U.S.
21.) Washington Examiner: Time for the truth about Gardasil (2010):
22.) New Concerns about the Human Papillomavirus Vaccine
===============================================================
===============================================================
 1.) Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
 ============================================================
 Nurs Clin North Am. 2009 Sep;44(3):293-9. doi: 10.1016/j.cnur.2009.06.005.

 Knudtson M1, Tiso S, Phillips S.
 Author information

 1
 Program in Nursing Science, Department of Nursing, University of California, Irvine, Irvine, CA 92697, USA. mdknudts@uci.edu

 Abstract

 Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the United States. This article gives an overview and discussion of HPV virus types and transmission, and the quadrivalent vaccine now available to protect against it. Included are the nursing implications for the HPV vaccine related to education and counseling of parents, patients, and young adult women regarding HPV vaccination, for whom the vaccine is indicated.
 ==============================================================
 2.) Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials.
 ==============================================================
 Basic Clin Androl. 2016 Nov 21;26:16. eCollection 2016.

 Macki M1, Dabaja AA2.
 Author information

 1
 Department of Neurosurgery, Henry Ford Hospital, Detroit, MI USA.
 2
 Vattikuti Urology Institute, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI 48202 USA.

 Abstractin English, French
 BACKGROUND:

 The human papilloma virus (HPV) infections were addressed with two FDA-approved HPV vaccines: quadrivalent and bivalent vaccine. The objective of this manuscript is to determine the safety of the HPV vaccine.
 RESULTS:

 A search of PubMed articles for "human papillomavirus vaccine" was used to identify all-type HPV clinical studies prior to October 2014. A refined search of clinical trials, multicenter studies, and randomized studies were screened for only randomized controlled trials comparing HPV vaccine to controls (saline placebo or aluminum derivatives). Studies were limited to the two FDA-approved vaccines. Following PRISMA guidelines, the literature review rendered 13 publications that met inclusion/ exclusion criteria. Gender was limited to females in 10 studies and males in 1 study. Two studies included both males and females. Of the 11,189 individuals in 7 publications reporting cumulative, all-type adverse events (AE), the AE incidence of 76.52 % (n = 4544) in the vaccinated group was statistically significantly higher than 67.57 % (n = 3548) in the control group (p < 0.001). The most common AE were injection-site reactions. On the other hand, systemic symptoms did not statistically significantly differ between the vaccination cohort (35.28 %, n = 3351) and the control cohort (36.14 %, n = 3198) (p = 0.223). The pregnancy/ perinatal outcomes rendered no statistically significant difference between the vaccine group and control group.
 CONCLUSION:

 Because the statistically significantly higher incidence of AE in the HPV vaccine group was primarily limited to injection-site reactions, the vaccinations are safe preventative measures in both males and females.
 ==============================================================
 3.) The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems.
 ==============================================================
 Immunol Res. 2015 Feb;61(1-2):90-6. doi: 10.1007/s12026-014-8567-3.

 Pellegrino P1, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, Radice S.
 Author information

 1
 Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital "Luigi Sacco", University of Milan, Via GB Grassi 74, 20157, Milan, Italy.

 Abstract

 The term "ASIA-Autoimmune/inflammatory Syndrome Induced by Adjuvants" describes an umbrella of clinical conditions sharing similar signs or symptoms, including post-vaccination phenomena. No information is available on the epidemiology of the ASIA syndrome, especially following HPV vaccination. We carried out an analysis of the VAERS database to retrieve all cases of suspected ASIA syndrome according to the Shoenfeld and Agmon-Levin's guideline for the diagnosis. After causality assessment and case validation, 2,207 cases were considered probably or possibly related to vaccination. These represent the largest ASIA cohort ever reported and allowed us to estimate epidemiological and clinical characteristic of this syndrome. The commonest clinical manifestation observed were pyrexia (58%), myalgia (27%) and arthralgia or arthritis (19%), and the estimated reporting rate was of 3.6 cases per 100,000 doses of HPV vaccine distributed (95% CI 3.4-3.7). This study presents the first systematic estimation of ASIA incidence and expands the knowledge on this pathology. Further analyses are needed to identify genetic and non-genetic risk factors for ASIA syndrome.
 ==============================================================
 3.) Evaluation of optic neuritis following human papillomavirus vaccination.
 ==============================================================
 Hum Vaccin Immunother. 2017 May 2:1-9. doi: 10.1080/21645515.2017.1310788. [Epub ahead of print]

 Sridhar G1, Tian F1, Forshee R2, Kulldorff M3, Selvam N1, Sutherland A4, Bryan W2, Barone S2, Xu L2, Izurieta HS2.
 Author information

 1
 a HealthCore Inc. , Alexandria , VA , USA.
 2
 b Center for Biologics Evaluation and Research, U.S. Food and Drug Administration , Silver Spring , MD , USA.
 3
 c Department of Population Medicine , Harvard Medical School , Boston , MA , USA.
 4
 d International Vaccine Access Center (IVAC), Department of International Health , Johns Hopkins Bloomberg School of Public Health , Baltimore , MD , USA.

 Abstract

 To assess the relationship between human papillomavirus (HPV) vaccination and occurrence of optic neuritis (ON) and to evaluate a claims-based algorithm for identification of ON. Females of 9-26 year olds in the HealthCore's Integrated Research Database (HIRDSM) with and without claims evidence of HPV vaccination between 2007 and 2012 were included in this study. Potential ON cases were identified using the claims-based algorithm, positive predictive value (PPV) was determined using medical chart review. For the claims analysis, two study designs, a self-controlled temporal scan statistic and a retrospective matched cohort analysis, were used. ON was defined based on an algorithm developed using diagnosis and procedure codes from the medical claims. The PPV for ON cases using charts that had enough information for reviewers to make a determination was 62.5% (95% CI: 49.5%-74.3%). With the self-controlled temporal scan statistic, the primary analysis restricting on recommended vaccination schedule timing showed an increased risk of potential ON after second dose (RR = 3.39; p = 0.03), this finding was not confirmed for any of the additional analyses performed for individual or combined doses. With the cohort design, there was no increased risk of potential ON following vaccination in either individual or combined dose analyses. The risk of potential ON was higher among participants with a history of prior autoimmune diseases. In conclusion, identifying confirmed ON cases through administrative claims data proved challenging. The claims-based analysis in this study did not provide evidence for an association of ON with HPV vaccination.
 =======================================================================
 4.) Literature review of vaccine-related adverse events reported from HPV vaccination in randomized controlled trials.
 =======================================================================
 Basic Clin Androl. 2016 Nov 21;26:16. eCollection 2016.

 Macki M1, Dabaja AA2.
 Author information

 1
 Department of Neurosurgery, Henry Ford Hospital, Detroit, MI USA.
 2
 Vattikuti Urology Institute, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI 48202 USA.

 Abstractin English, French
 BACKGROUND:

 The human papilloma virus (HPV) infections were addressed with two FDA-approved HPV vaccines: quadrivalent and bivalent vaccine. The objective of this manuscript is to determine the safety of the HPV vaccine.
 RESULTS:

 A search of PubMed articles for "human papillomavirus vaccine" was used to identify all-type HPV clinical studies prior to October 2014. A refined search of clinical trials, multicenter studies, and randomized studies were screened for only randomized controlled trials comparing HPV vaccine to controls (saline placebo or aluminum derivatives). Studies were limited to the two FDA-approved vaccines. Following PRISMA guidelines, the literature review rendered 13 publications that met inclusion/ exclusion criteria. Gender was limited to females in 10 studies and males in 1 study. Two studies included both males and females. Of the 11,189 individuals in 7 publications reporting cumulative, all-type adverse events (AE), the AE incidence of 76.52 % (n = 4544) in the vaccinated group was statistically significantly higher than 67.57 % (n = 3548) in the control group (p < 0.001). The most common AE were injection-site reactions. On the other hand, systemic symptoms did not statistically significantly differ between the vaccination cohort (35.28 %, n = 3351) and the control cohort (36.14 %, n = 3198) (p = 0.223). The pregnancy/ perinatal outcomes rendered no statistically significant difference between the vaccine group and control group.
 CONCLUSION:

 Because the statistically significantly higher incidence of AE in the HPV vaccine group was primarily limited to injection-site reactions, the vaccinations are safe preventative measures in both males and females.
 ========================================================================
 5.) Adverse events following HPV vaccination, Alberta 2006-2014.
 ========================================================================
 Vaccine. 2016 Apr 4;34(15):1800-5. doi: 10.1016/j.vaccine.2016.02.040. Epub 2016 Feb 26.

 Liu XC1, Bell CA2, Simmonds KA3, Svenson LW4, Russell ML5.
 Author information

 1
 Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada T2N 4Z6. Electronic address: xcliu@ucalgary.ca.
 2
 Epidemiology and Surveillance Team, Alberta Ministry of Health, 23rd fl Telus Plaza NT, 10025 Jasper Avenue, Edmonton, AB, Canada AB T5J 1S6. Electronic address: chris.bell@gov.ab.ca.
 3
 Epidemiology and Surveillance Team, Alberta Ministry of Health, 23rd fl Telus Plaza NT, 10025 Jasper Avenue, Edmonton, AB, Canada AB T5J 1S6. Electronic address: kimberley.simmonds@gov.ab.ca.
 4
 Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada T2N 4Z6; Epidemiology and Surveillance Team, Alberta Ministry of Health, 23rd fl Telus Plaza NT, 10025 Jasper Avenue, Edmonton, AB, Canada AB T5J 1S6; School of Public Health, University of Alberta, Edmonton, AB, Canada T6G 1C9. Electronic address: larry.svenson@gov.ab.ca.
 5
 Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada T2N 4Z6. Electronic address: mlrussel@ucalgary.ca.

 Abstract
 BACKGROUND:

 In Canada, private purchase of human papilloma virus (HPV) vaccines has been possible since 2006. In Alberta, Canada, a publicly funded quadrivalent HPV vaccine program began in the 2008/2009 school year. There have been concerns about adverse events, including venous thromboembolism (VTE) associated with HPV vaccines. We describe the frequencies of adverse events following HPV vaccination among Alberta females aged 9 years or older and look at VTE following HPV vaccination.
 METHODS:

 We used the Alberta Immunization and Adverse Reaction to Immunization (Imm/ARI) repository (publicly funded vaccine), the population-based Pharmaceutical Information Network (PIN) information system (dispensing of a vaccine), and the Alberta Morbidity and Ambulatory Care Abstract reporting system (MACAR) for June 1, 2006-November 19, 2014. Deterministic data linkage used unique personal identifiers. We identified all reported adverse events following immunization (AEFI) and all emergency department (ED) utilization or hospitalizations within 42 days of immunization. We calculated the frequency of AEFI by type, rates per 100,000 doses of HPV vaccine administered and the frequencies of ICD-10-CA codes for hospitalizations and emergency department visits.
 RESULTS:

 Over the period 195,270 females received 528,913 doses of HPV vaccine. Of those receiving at least one dose, 192 reported one or more AEFI events (198 AEFI events), i.e., 37.4/100,000 doses administered (95% CI 32.5-43.0). None were consistent with VTE. Of the women who received HPV vaccine 958 were hospitalized and 19,351 had an ED visit within 42 days of immunization. Four women who had an ED visit and hospitalization event were diagnosed with VTE. Three of these had other diagnoses known to be associated with VTE; the fourth woman had VTE among ED diagnoses but not among those for the hospitalization.
 CONCLUSIONS:

 Rates of AEFI after HPV immunization in Alberta are low and consistent with types of events seen elsewhere.
 ========================================================================
 6.) Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
 =======================================================================
 Vaccine. 2011 Jun 20;29(28):4601-7. doi: 10.1016/j.vaccine.2011.04.050. Epub 2011 May 5.

 van Klooster TM1, Kemmeren JM, van der Maas NA, de Melker HE.
 Author information

 1
 Department of Epidemiology and Surveillance, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

 Abstract

 In 2009, human papillomavirus (HPV) vaccination was offered to girls born in 1993-1996 in a catch-up campaign, followed in 2010 by the implementation of the vaccination in the National Immunization Programme (NIP) for girls born in 1997. To monitor the tolerability of the 2009 catch-up campaign, we investigated the occurrence of adverse events within 7 days after vaccination with the bivalent HPV vaccine. A total of 6000 girls were asked to participate, including 1500 from each birth cohort from 1993 to 1996. One week after each of the required three successive doses, the participants received by e-mail a Web-based questionnaire focused on local reactions and systemic events. One or more questionnaires were returned by 4248 girls. Any local reaction was reported by 92.1% of the girls after the first dose, 79.4% after the second dose, and 83.3% after the third dose, and 91.7%, 78.7%, and 78.4% reported any systemic event after the three doses, respectively. Pain in the arm was the most frequently reported local reaction, of which 24.0%, 11.7%, and 14.7% was classified as pronounced. Myalgia was the most often reported systemic event. The proportion of local reactions and most systemic events was significantly lower after the second and third dose compared with the first dose (Odds ratio [OR], 0.33-0.76). Older girls reported a higher proportion of adverse events than younger girls. After vaccination with the bivalent HPV vaccine, girls 13-16 years of age reported a high proportion of short-term adverse events. These are maximum estimates and not necessarily caused by the vaccination itself. Although, girls experienced HPV vaccination as painful, no serious or unexpected adverse events were reported. The results of this survey are being communicated to health care workers and the public.
 ========================================================================
 6.) The Nordic Cochrane Collaboration
 ========================================================================

 Source: medium.com/@jbhandley/hpv-gardasil-injury-scandals-worldwide-why-is-u-s-media-silent-parents-beware-86b416691f5b

 According to their website, the Nordic Cochrane Collaboration is:

 “an independent research and information centre that is part of the Cochrane Collaboration, an international network of individuals and institutions committed to preparing, maintaining, and disseminating systematic reviews of the effects of health care.”

 The Cochrane Collaboration is a highly respected international organization, which makes the complaint they filed with the European Medicines Agency all the more amazing. Cochrane is accusing the EMA of not being honest with Europeans about the risk-benefit of the HPV vaccine.

 Here’s one quote from the complaint, the full 19 page complaint is accessible from the link:

 “The prominent symptoms, which are suspected of being caused by the vaccine, are similar to those seen in so-called functional disorders such as chronic fatigue syndrome (CFS) and include postural orthostatic tachycardia syndrome (POTS) and chronic regional pain syndrome (CRPS). The hypothetical mechanism is an autoimmune reaction triggered by either the active component of the vaccine or the adjuvant in the vaccine. These syndromes are difficult to diagnose; their causes are poorly understood; and they are likely to be underreported. This complicates studies of a causal link.

 The EMA’s official report gives the impression of a unanimous rejection of the suspected harms. However, only seven months earlier, the EMA had resolved that “A causal relationship between the dizziness and fatigue syndrome, Postural Orthostatic Tachycardia Syndrome (POTS) and Gardasil [one of the HPV vaccines] can neither be confirmed nor denied” . Moreover, the EMA’s internal report of 256 pages, which provided the draft for its 40-page official report, tells a very different story. The internal report is confidential but has been leaked.”

 And their conclusion:

 “As far as we can see, the actions of the EMA in this case indicates that the agency is more concerned about protecting its own previous decisions and the vaccine than about protecting the citizens and giving them the option of choosing for themselves whether or not they would like to get vaccinated against HPV. Some people will prefer to avoid the vaccine, even if the risk of serious harm is very small, and some will prefer screening instead. It is not within the powers of regulatory authorities to deny citizens’ right to make informed choices about their own health by withholding important information. The citizens need honest information about the vaccine and the uncertainties related to it; not a paternalistic statement that all is fine based on a flawed EMA report (2).”
 ========================================================================
 7.) An International Brushfire
 ========================================================================
 Source: medium.com/@jbhandley/hpv-gardasil-injury-scandals-worldwide-why-is-u-s-media-silent-parents-beware-86b416691f5b


 There are so many stories around the world about protests and controversy surrounding the HPV vaccine, it’s hard to keep up, so I will just go country by country, in no particular order, and I hope every parent can do their own research and decide if getting the HPV vaccine provides a reasonable risk-reward for their daughter or son.

 =======================================================================
 8.1.) Japan, HPV Vaccination Controversy in Japan, Rates Plummet to 1%
 =======================================================================
 Source: medscape.com/viewarticle/866405

 HPV Vaccination Controversy in Japan, Rates Plummet to 1%

 Roxanne Nelson, BSN, RN

 July 20, 2016
 Controversy over human papillomavirus (HPV) vaccination in Japan has led to much confusion among healthcare professionals and parents, with the result that vaccination rates have plummeted, from around 70% to only 1%.

 The situation in Japan is summarized by Ryo Konno, MD, of Jichi Medical University, Saitama Medical Center, Japan, speaking in a Lancet Oncology podcast that accompanied an article reviewing breast and cervical cancer screening.

 Dr Konno explains that the Japanese government withdrew its recommendation for the HPV
 vaccine in 2013, after highly publicized cases of alleged adverse events in girls who had been vaccinated. He also says that the side effects are "a psychosomatic reaction" and that the whole controversy was started by an anti-HPV vaccination group.

 Dr Konno recalls, "In March 2013, just before the start of a national HPV vaccination program in Japan, there was a major report without any medical evidence that some girls had suffered from severe and chronic pain as a result of the HPV vaccination."

 That report, which appeared in the Japanese daily newspaper Asahi Shimbun, gave details of about 50 girls who suffered from complex regional pain syndrome and 100 girls who were absent from school after receiving the HPV vaccine.

 According to Dr Konno, this report "was based on information that came from an anti-HPV vaccination group called Vaccine Victims.... These so-called victim girls were put at the forefront of the TV cameras and seen by a large audience."

 The story became sensationalized and was repeated on television news programs and then on Internet websites by victim groups, Dr Konno said.
 A few months later, in June 2013, the Japanese Ministry of Health, Labor and Welfare (MHLW) withdrew its recommendation for the HPV vaccine because of these reports of serious side effects associated with vaccination, but the vaccines were not withdrawn from the market.

 The Minister of Health has said that girls can be vaccinated if parents understand the risks and benefits of the vaccine, but the vaccines could not be actively promoted, Dr Konno explained.
 In the meantime, Japan has put in place a scheme to deal with chronic symptoms after HPV vaccination.

 A Rocky Road

 In Japan, the HPV vaccine Cervarix (GlaxoSmithKline) was approved in 2009; the vaccine Gardasil (Merck & Co) was approved in 2011.

 A summary of the HPV vaccination program in Japan was published in May 2014 by the Center for Strategic and International Studies (CSIS). The report was authored by researchers from the Department of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine in the United Kingdom.

 From 2009, Cervarix was partly funded by the Suginami local government. By April 2010, 32 of the 1747 local governments had decided to provide funding for the HPV vaccine. In October 2010, the central and all local governments launched a temporary funding program, and in April 2013, the HPV vaccine was included in the National Immunization Program (but was optional) and was given for free," according to the CSIS report.

 The report also notes that by June 2013, an estimated 8.29 million people in Japan had received the HPV vaccine.

 The report notes that the MHLW announcement of the withdrawal of its recommendation for HPV vaccination was made on June 14, 2013, a day after the World Health Organization (WHO) declared the HPV vaccine to be safe.

 The MHLW issued a nationwide notice that although the HPV vaccine could still be given for free to girls aged 12 to 16 years, it should not be proactively promoted. At the time, it said that it was necessary to gather information about the side effects that had been reported.

 On the day the announcement was made, a press conference was held by the Vaccine Adverse Reactions Review Committee featuring girls who alleged that they had been affected by the HPV vaccine. The report notes that the girls reported experiencing convulsions, seizures, severe headaches, and partial paralysis.

 The report also notes that concerns about the HPV vaccine spread through Japanese social networks. "The absence of any media watchdog in Japan and the relatively lax libel laws mean that newspapers, news programs, social networks and victim support groups are able to publish unverified stories and videos of girls who claim to suffer from adverse events following HPV vaccination," the report authors comment.

 Recalling the events, Dr Konno comments in the podcast: "On June 13, the WHO released a safety statement assuring us that the vaccine was safe, but the next day, the Japanese government decided to withdrew its recommendation for the vaccine.... The Ministry of Health did not correct the false claims that had been publicized because they did not have sufficient data to assess the causality of the events."

 In December 2014, a symposium held by the Japan Medical Association and the Japanese Association of Medical Sciences concluded that HPV vaccines should be promoted only after issues regarding vaccine safety were settled.

 "In general, it is never appropriate to discontinue the immunization program while awaiting the completion of an investigation," Dr Konno asserts.

 But that is precisely what happened in Japan, and now it has made an investigation very difficult. "There is serious confusion over medical and legal terms," he noted.

 Dr Konno emphasized that in 2013, the Minister of Health did not clearly communicate whether there was a causal relationship between the vaccine and the adverse events but said only that girls could be vaccinated if parents understood the risks and efficacy. Yet the vaccine could not be actively promoted.

 "Health officials were so confused," he said. "Consequently, coverage from the vaccine dropped from 70% to only 1%."

 He noted that in 2014, a committee associated with the Ministry of Health concluded that there was no evidence to suggest a causal link between chronic pain and the HPV vaccine. "The committee concluded that the girls were suffering from a functional somatic disorder caused by a psychosomatic reaction, so-called conversion disorder," Dr Konno said.

 The girls were suffering from a functional somatic disorder caused by a psychosomatic reaction. Dr Ryo Konno

 Yet the Ministry of Health did not provide sufficient communication about this, Dr Konno commented, and media reports have been the only source of information for the public and health professionals for more than 3 years since the recommendation for the vaccine was withdrawn.

 Dr Konno notes that a large body of evidence has shown that the benefit of the vaccine outweighs any risk. "But very few newspapers in Japan have reported these international statements, and the TV news has ignored them and reports mostly about the victims.
 This is no longer a medical decision but an emotional-based policy. Dr Ryo Konno

 "The Minister of Health still cannot decide to resume the vaccine based on scientific evidence," Dr Konno said. "This is no longer a medical decision but an emotional-based policy."

 At the EUROGIN Congress that was held last month in Salzburg, Austria, Dr Konno noted more than 300 of his colleagues from many countries have agreed to sign a petition asking the Japanese government to reinstate the HPV vaccination program.

 In addition, a group of Japanese experts in obstetrics and gynecology has recently called for the Ministry to reinstate its recommendation for HPV vaccination, warning that otherwise there may be an increase in "highly preventable cervical and other HPV-related cancers."

 Class Action Lawsuit

 But the situation in Japan has become more complicated.

 On July 27, a class action lawsuit will be filed against the Japanese government, which launched the national vaccination program, and the two manufacturers of the HPV vaccine in four district courts. The lawsuit is being filed on behalf of girls and women who say that they have suffered severe side effects as a result of receiving the vaccine.

 When the lawsuit was first announced, there were 12 plaintiffs, aged 10 to 20 years, but according to the Japan Times, that number has since mushroomed to 64. Of this group, 28 will lodge their suit with the Tokyo District Court, six with the Nagoya District Court, 16 with the Osaka District Court, and 14 with the Fukuoka District Court.

 They plan to demand ¥15 million ($140,682) in damages for each plaintiff, for a total of ¥960 million ($9 million), and may increase the amount in the future, depending on their symptoms.

 The lawyers claim that the government's approval of the vaccine was illegal. They claim that the vaccine has caused nerve disorders and other problems due to the excessive immune reactions associated with its use. In addition, they say that the manufacturers bear product liability.

 As quoted in the Japan Times, lawyer Masumi Minaguchi stated, "We aim to clarify the responsibilities of the government and the drugmakers through the lawsuits so that the victims can live without anxiety."

 More Confusion Over Compensation

 Independently of the lawsuit, several local governments have compensated girls for health problems believed to be related to HPV vaccination.

 But there is confusion over the vaccine compensation program, comment Koichiro Yuji, MD, PhD, from the Institute of Medical Science at the University of Tokyo, Minatoku, and Haruka Nakada, JD, PhD, of the National Cerebral and Cardiovascular Center in Osaka, writing in an article published in Human Vaccines and Immunotherapeutics.

 In Japan, approximately 3.38 million girls were vaccinated, and 2584 have complained of health problems, they report. A total of 98 girls who developed health problems applied for assistance from 2011 to 2014.



 The majority of these girls (90%) received the HPV vaccine as a nonroutine vaccination, and according to the MHLW, 186 of the girls (0.005%) have not recovered from these events.

 As of October 2014, no further cases have been processed. A total of 27 cases were settled, with 18 patients receiving compensation. Nine cases have been declined. The national program for HPV vaccine injury is currently suspended; 71 cases are still pending.

 After the national program was suspended, a few of the local governments provided compensation programs for these cases, but the number doing so is extremely low — only 16 of 1741 municipalities and 1 of 47 prefectures.

 The authors emphasize that the current situation is "confusing due to the discrepancy in HPV vaccine injury compensation between those who received vaccinations under the immunization law and those who received them voluntarily."

 HPV vaccine injury compensation programs also differ depending on whether the person was vaccinated before or after April 2013, when the Preventive Vaccination Law was amended.

 Those who received routine vaccinations are able to be reimbursed for their medical expenses for both outpatient and inpatient treatment from the MHLW. For those who received nonroutine vaccinations, financial assistance is available from the Pharmaceuticals and Medical Devices Agency on the condition that the health problems warrant the equivalent of hospitalization.

 The Ministry of Health is now planning to correct this discrepancy by increasing the level of assistance provided to those with health conditions stemming from nonroutine vaccinations, the authors note. In addition, the ministry plans to consult with an expert panel to draw up its relief program.

 "No-fault compensation following adverse events attributed to vaccination is key for vaccine implementation, and the establishment of a new compensation program might be key to calming an anxious public in Japan," write Dr Yuji and Dr Nakada.

 They also point out that efforts at compensation seem to be influenced primarily by the activities of HPV vaccine victim support groups and that overall, the suspension of the recommendation for the HPV vaccine has had a negative effect on global health.

 "The Japanese government must manage the symptoms that sometimes follow the vaccination, restore public confidence, and provide a strong, evidence-based communication plan for the HPV vaccine," they conclude.

 Dr Konno has received honoraria from Roche Diagnostics and BD and is the director of the Executive Board Members of the Japanese Expert Board for the Eradication of Cervical Cancer, which has received unrestricted funding from Qiagen; Merck, Sharp & Dohme; and GlaxoSmithKline. Dr Yuji and Dr Nakada have disclosed no relevant financial relationships. Their article was supported by Grant-in-Aid for Scientific Research.

 Lancet Oncol. 2016;16:e305-e312. Abstract

 Hum Vaccin Immunother. 2016;12:1321-1324. Abstract
 ========================================================================
 9.2.) Denmark, TV2 Denmark Documentary on HPV Vaccine Shows Lives of Young Women Ruined
 ========================================================================
 Source: healthimpactnews.com/2015/tv2-denmark-documentary-on-hpv-vaccine-shows-lives-of-young-women-ruined/

 TV2 Denmark Documentary on HPV Vaccine Shows Lives of Young Women Ruined

 Excerpt: TV2 Denmark has done something no mainstream media network in the United States will dare to do: look into the controversial HPV vaccine that many have claimed has ruined the lives of so many young women, and publish an investigative report.

 In December of 2013 Katie Couric did a show on the HPV Gardasil Vaccine where she dared to interview the mother of a young woman who died shortly after receiving the vaccine. Couric’s program was hardly pro-vaccine, as she gave both sides of the controversy, with a huge emphasis on the pharmaceutical side claiming the vaccine was safe, but she was viciously attacked by the mainstream media anyway and forced to apologize for even asking questions about the possible risks of the HPV vaccine.

 With such censorship so obvious in the U.S. mainstream media, it is refreshing to see the Danish media make this documentary available with English subtitles for the rest of the world to watch. Families and doctors are interviewed, and the tough questions are not censored. Similar to the U.S., these vaccine-damaged girls can find no help from their government since the vaccine injuries are vigorously denied by their government, leaving them and their parents feeling “betrayed.”
 ========================================================================
 10.) 3. Ireland
 =======================================================================
 Source: thejournal.ie/hpv-vaccine-2500090-Dec2015/
 youtube.com/watch?v=eh2Q5bzPw-4
 Irish parents are stopping their children from getting a cervical cancer vaccine — but why? (April 2016)

 Excerpt: Late last year, various media outlets (including this publication) highlighted the cases of over 130 girls and their families who claimed that their daughters had become ill after having received the vaccine.

 The parents and their daughters, many of whom are members of an advocacy group named REGRET (Reactions and Effects of Gardasil Resulting in Extreme Trauma), also had their efforts to find out what was the cause of their daughters’ illnesses chronicled in a documentary entitled Cervical Cancer Vaccine: Is it Safe?, which aired on Tv3 on 14 December.
 Irish parents are stopping their children from getting a cervical cancer vaccine - but why?

 Public health professionals are blaming recent negative media coverage for the drop in uptake.
 thejournal.ie (www)

 Check out the video produced by the parent led activist group in Ireland: called REGRET:
 youtu.be/Uzgn0z8R2zQ
 ========================================================================
 11.4.) Colombia, MAY 6, 2014 Gardasil Scandal Brewing in Colombia?
 ========================================================================
 Source: counterpunch.org/2014/05/06/gardasil-scandal-brewing-in-colombia/

 MAY 6, 2014 Gardasil Scandal Brewing in Colombia?

 by MARIO LAMO JIM_NEZ

 María Paula Mejía, one of Colombia’s first Gardasil victims?

 Her name is María Paula Mejía. She is a college student. Since receiving three doses of Gardasil her health has deteriorated considerably. She now suffers from constant pain throughout her body, muscle weakness, and bleeding from the nose and gums. She has so much pain in her left knee and ankle that she must walk with a cane, and cannot continue her college education. Paula is one of the first in Colombia to report a serious new medical conditions occurring after the use of Gardasil.

 Lloyd Phillips, an American researcher of infectious diseases and genetics, has studied the adverse effects of Gardasil for five years. His work has revealed how Gardasil works differently in different people. He has documented related and biologically plausible mechanisms of action which could cause the many serious and life-threatening side effects which are being reported by girls and young women around the world after receiving the HPV vaccine.

 In Colombia we have a potential crisis of major proportions resulting from the use of Gardasil because it is “free and compulsory” by “Law of the Republic”. It is assumed that this HPV vaccine is effective when used to combat cervical cancer, which can be caused by human papilloma virus. However, this vaccine has been hotly debated internationally for allegedly being dangerous and ineffective. It is currently being administered in Colombia without obtaining informed consent from young girls and their parents as to the potential and unknown risks of use.

 The director of vaccination at MOH (Ministry of Health), Alejandro Garcia, says the government is “confident in the report of the World Health Organization,” which gives the go-ahead to the vaccine and assures that there is no association between the developments of illness and application of the vaccine.

 Lina Trujillo of the Colombian Cancer Institute says that the vaccine protects exclusively against HPV and “does not remove the possibility of having other diseases, and adolescence is the time at which diseases such as lupus and rheumatoid arthritis start to appear,” and that “the only contraindication is ‘pregnancy’ and specialists have no hesitation in recommending the vaccine.”

 However, neither the director of the Ministry of Health nor Lina Trujillo, from the Colombian Cancer Institute seem to be informed about how the vaccine is produced, and much less about the potential side effects of Gardasil.

 The World Health Organization, whose reports are practically the Bible of the Gardasil vaccination policy in Colombia, has been suggested to be complicit with the pharmaceutical industry in general and the Gardasil manufacturer in particular in urging promotion of HPV vaccination campaigns. Relying on the pharmaceutical industry to self-regulate has historically been a losing proposition for the public when companies are left to weigh profits against transparency.

 The María Paula Mejía case is illustrative in this regard. She had a third dose of the vaccine, even though she had experienced adverse symptoms after the first two injections. The third injection is when her serious symptoms began.

 Interviewed via Skype, with visible signs of pain and discomfort from the effort of sitting upright in a chair, she told us the symptoms she experienced after the third dose of vaccine.

 During the first 15 days after her third injection she experienced fever, vomiting, diarrhea, bone pain, joint pain, migraines, tingling, electrical “zaps” on her hip and back, and neck pain. One day she was unable to move for 2 hours, and continues to suffer from insomnia and dizziness. María Paula had every expectation that the symptoms would abate or at least become less intense, but instead they progressed in severity.

 At her medical appointments, during which she was subjected to more than 40 laboratory tests, the medical diagnosis was unanimous: All tests were perfectly “normal”, she had nothing … while her symptoms worsened.

 The symptoms she was already experiencing were followed by more severe ones, which included progressively spreading joint and bone pain, worsened neck pain, scalp pain, continuing severe hip, back, and knee pain. She began to suffer loss of strength in the left leg, wrist pain, dizziness, neuralgia throughout the body, painful spinal “zaps” as well as continuation of the “zaps” in her hips and limbs. She began to suffer difficulty breathing at certain times of day, chest pain, bleeding in the nose and gums, deviation of the left knee and left ankle, and new complications from older problems.

 Through all these symptoms, medical observations and tests were useless in arriving at a diagnosis until a doctor thought to ask: “Has she been recently vaccinated?”

 It was then that María Paula first made the association between the vaccine and her new medical condition. And she was not mistaken.

 She is currently overwhelmed by pain, has difficulty walking and feels her health is deteriorating more and more. Her symptoms are consistent with those being reported after Gardasil around the world. Although not all are affected equally, of all girls who are vaccinated, a percentage of them will suffer severe effects from Gardasil, which can lead to paralysis and even death.

 Neither Merck, the manufacturer, nor the Colombian government agrees that the vaccine is causing these severe symptoms. Both simply raise an accusatory finger at those who denounce this situation, as if the victims did not exist.

 The reproductive health of girls and Colombian youth’s rights are being denied to those injected with Gardasil. This is not acceptable, particularly since government support for HPV vaccines has been withdrawn in other countries, such as Japan, for example, because of concerns about serious adverse reactions including infertility.

 What’s more, says researcher Lloyd Phillips, if a girl who already has HPV is vaccinated, her risk of getting cancer could substantially increase.

 Colombian doctors do NOT know, or refuse to accept, the risks of this vaccine. Treatment for victims is nonexistent.

 This is what the U.S. researcher Lloyd Phillips explained to me about Gardasil:

 The vaccine uses an aluminum adjuvant because in 1920 a man named Glinny discovered that aluminum stimulated the immune system. A Frenchman named Ramón then discovered that if the aluminum-containing vaccine was given to a horse that had an infection, the immune system produced an even greater amount of antibodies.

 Phillips found that aluminum remaining in the system after Gardasil injections can cause an enhanced and extended immune response against infections and illnesses that occurred long ago.

 This enhanced response can cause inflammation in the body, especially in the digestive system, and can cause the immune system to wrongfully identify food proteins as foreign. The body then begins to produce histamine to combat what it perceives as a food allergy, causing stomach pain and dilating blood vessels, which can cause dizziness and excessive heart pounding upon standing up.

 The result, according to Phillips, is that the more inflamed a digestive tract becomes, the more its ability to absorb nutrients needed to maintain the chemical cycles in the body can become impaired, which can lead to fatal consequences.

 Phillips also notes that the body cannot distinguish between inflammation and fear, either of which can trigger the “fight or flight response” which forces the person to excrete magnesium, causing a deficiency. This deficiency has many symptoms, such as muscle spasms, pain, irritability, cardiac arrhythmias, headaches, brittle bones, and more.

 In short, says the researcher, this type of vaccine was made for people with “a genetically perfect immune system,” which does not exist in reality.

 Gardasil can produce all of these symptoms to varying degrees according to the genetic make-up and medical condition of the person who receives the vaccine, which can vary from hour to hour. This is something neither Merck, nor the Colombian government is telling the public.

 In the case of María Paula, as she will recount, when she received the first dose, she was never warned that any of the symptoms she is now suffering were possible. She says:

 “They told me that I could have pain in my arm for a week and that I had to wait 15 minutes before leaving the Cancer League, because some girls fainted and the next week was going to be uncomfortable, but that it was normal because of the vaccine… I received the second dose and the second dose hurt a little more … the next few months I began to experience fatigue and back pain, but I thought it was because of my daily activities … I had pain in the lower back and neck … I received the third dose on 20 January of this year and the pain was much greater than in the previous two doses … I began to experience several things … immediately after being vaccinated I began to experience dizziness, I wanted to throw up, obviously my arm really hurt … they warned me about the dizziness, and the urge to vomit and the arm pain and that the next day my arm was also going to hurt, but the following week I had fever, vomiting, diarrhea, extremely strong migraines that lasted 15 days with vomiting, and diarrhea…, I went to the doctor and was told that that there was a virus going around… one night I sat on the couch in my house and then I lay down; I started feeling really bad, very feverish, until I realized that I could not get up from the couch “…

 María Paula’s symptoms seem to get worse with each passing day. For the moment, the only hope she has of improving is going to the U.S. to receive treatment.

 In Colombia there is no protocol to treat these cases. The government says they do not exist.

 And what is the role of Merck, the manufacturer of the vaccine?

 According to Lloyd Phillips, company profits are what motivates the existence of this vaccine and its advertising campaigns, due to lawsuits against Merck as a result of VIOXX, a drug that caused 27,000 heart attacks. A single dose of Gardasil may cost about 68 cents to produce (about $ 1360 pesos), and in Colombia obtaining it privately costs the equivalent of $60 (roughly $120 thousand pesos) and in the USA up to $ 200 (about 400 thousand pesos).

 The Colombian government has spent $300 million on a questionable vaccine that is already starting to claim apparent victims in Colombia. Following Lloyd Phillips’ statistics, of the $300 million paid by Colombia, $ 298.98 million (nearly $299 million) was profit for Merck.

 Colombia is purchasing the HPV vaccine at a hugely inflated price. This vaccine can not only ruin lives, but can cost thousands of dollars to bring a single victim back to health. Families may have to spend thousands of dollars trying to restore their daughters’ health, without having prevented any cancer as promised, and instead causing a number of illnesses that did not exist before using this ‘miracle’ vaccine.

 We are then faced with a health emergency induced by a vaccine that has never been proven to prevent any cancer and that is ravaging the children and youth around the world, against which there have been million-dollar awards for HPV vaccine injury in the U.S. (The U.S. government has already paid more than six million dollars to victims) and the vaccine has been rejected in several countries, for example in India and Japan.

 But in Colombia, Gardasil will continue to claim more casualties unless an immediate halt to its “free and compulsory” status is granted.

 The Colombian government is exposing itself to millions of dollars in lawsuits for its actions in making this vaccine mandatory to Colombian girls and women without informing them of the grave risks already known worldwide.

 Does the government of Colombia intend to ignore medical consumers’ right to informed consent, despite knowing the consequences?

 MARIO LAMO JIMÉNEZ is a founding member of the Colombian Alliance of Writers and Journalists and coeditor of its publication “La Hojarasca“. He can be reached at admin@escritoresyperiodistas.com.

 ========================================================================
 12.) Mystery illness plagues girls in Colombia
 ========================================================================
 Source: yahoo.com/news/mystery-illness-plagues-girls-colombia-052825963.html?ref=gs

 El Carmen de Bolivar (Colombia) (AFP) — A mystery illness is plaguing girls in this town in northern Colombia, and locals say a vaccine against the sexually transmitted human papillomavirus, or HPV, is to blame.

 First their hands and feet feel cold. Then they go pale and cannot move. Some convulse and fall to the floor.

 In El Carmen de Bolivar, near the port of Cartagena, dozens of teenagers have experienced similar symptoms. Some have even lost consciousness.

 “They vaccinated me in May and I started fainting in August. My legs became heavy and I couldn’t feel my hands anymore. When I woke up, I was in the hospital,” recalled 15-year-old Eva Mercado.

 She passed out seven times in a month.

 For most of the families affected in this town of 67,000, there is no doubt about what is causing the problem.

 They place the blame squarely on a vaccination campaign against HPV, one of the most common sexually transmitted diseases, which can trigger cervical cancer.

 The city’s modest Nuestra Senora del Carmen hospital has been overwhelmed by a surge of unconscious teenage girls being wheeled through its doors.

 Panicked fathers bring their daughters to the facility aboard their motorcycles, using the town’s dirt roads.

 Doctors search, in vain, for possible cases of hypoglycemia or drug abuse.

 According to hospital official Augusto Agamez, about 370 minors have checked into the facility. There was also one boy among them.

 “There is no diagnosis or specific treatment,” Agamez told AFP, stressing that the hospital was also helping families cope with the unknown illness.
 ========================================================================
 13.5.) Sweden, Swedish cover-up of HPV vaccine side effects — and more
 =========================================================================
 Swedish cover-up of HPV vaccine side effects — and more

 Source: anhinternational.org/2015/11/04/swedish-cover-hpv-vaccine-side-effects/

 Excerpt: Emerging on Swedish radio news over recent days have been revelations by a Swedish MPA scientist, Rebecca Chandler, who had been charged with running studies to investigate the risk of one particular side effect, Postural Tachycardia Syndrome (PoTS). This is a life-altering and debilitating condition characterised by orthostatic intolerance (the development of symptoms when upright that are relieved by lying down). Symptoms include headaches, fatigue, palpitations, sweating, nausea, fainting and dizziness and a greatly elevated heart rate when upright. A Danish study published earlier this year found that 60% of adolescent girls suffer from PoTS, the symptoms being initiated within hours of vaccination. The cluster of symptoms is increasingly being referred to among sufferers as Post-Gardasil Syndrome or PGS.

 When news from Denmark revealed the extent of the PoTS cases linked temporally with Gardasil vaccination, the MPA decided — of all things — to terminate its trial. Rebecca Chandler, who was becoming increasingly convinced that PoTS was a significant side effect, objected. But the MPA wasn’t about to change its mind. Her sense of concern and disillusionment triggered her resignation from the MPA, and she has now blown the whistle on the events, despite this news not being broadcast through mainstream media channels (typical of attempted cover-ups of this type).
 ========================================================================
 14.6.) New Zealand Cause or coincidence? (November 2015)
 ========================================================================
 Source: newshub.co.nz

 The vaccination to help prevent cervical cancer has been on offer here since 2008 and more than 200,000 New Zealand girls have had it. The scientists say it’s safe, but some girls and their families have serious doubts. They want to know whether Gardasil is to blame for what’s happened to them. In two cases, that was sudden, unexplained death. In others, crippling illness.

 Watch the video for the full 3D report: newshub.co.nz/tvshows/3d/cause-or-coincidence-teen-dies-after-gardasil-vaccine-2015110813 (the link is broken)
 ========================================================================
 15.7.) Spain, : Spain Joins Growing List of Countries to File Criminal Complaints
 ========================================================================
 Source: healthimpactnews.com/2014/gardasil-vaccine-spain-joins-growing-list-of-countries-to-file-criminal-complaints/

 Gardasil Vaccine: Spain Joins Growing List of Countries to File Criminal Complaints (Dec 2016)
 “The complaint states that Merck Laboratories failed to use an inert placebo during clinical trials, thereby manipulating data and marketing Gardasil under false pretences. Despite complaints of several young women with similar new medical conditions after Gardasil injections, the Spanish health authorities ignored calls for a moratorium on the use of Gardasil until the safety issues were resolved.”

 Spain now joins a growing list of countries where criminal lawsuits have been filed against manufacturers of the HPV vaccine, which includes France, India, Japan, and many more.

 In the United States, however, you cannot sue the manufacturers of vaccines, as they are protected from civil criminal prosecution. As a result, marketing efforts to increase the sale and distribution of the HPV vaccine are increasing. (See: Merck aims to boost HPV vaccination rates amid lagging numbers)
 =============================================================================
 16.) Gardasil: Criminal complaint filed in Spain
 =============================================================================

 By Norma Erickson

 SaneVax, Inc.

 June 19 2014, Logroño, Spain: Attorney Don Manuel Sáez Ochoa filed a criminal complaint against Merck-Sanofi Pasteur Laboratories, Spanish National Health authorities, and the regional health authorities of the La Rioja province on behalf of Zuriñe Jiménez Guereño and her mother Doña Maria del Carmen Jiménez Guereño for injuries and disabilities suffered by Zuriñe after the administration of Gardasil.

 The complaint states that Merck Laboratories failed to use an inert placebo during clinical trials, thereby manipulating data and marketing Gardasil under false pretences. Despite complaints of several young women with similar new medical conditions after Gardasil injections, the Spanish health authorities ignored calls for a moratorium on the use of Gardasil until the safety issues were resolved.

 Both regional and national health authorities made no attempt to verify the accuracy of the safety data Merck submitted to gain approval for the widespread administration of Gardasil as a cancer preventative; nor did they make any attempt to inform the public that an already proven safe and effective means of controlling cervical cancer was already in existence.

 The complaint goes on to say both national and local health authorities had adequate knowledge regarding the potential harmful effects of Gardasil and chose to recommend administration of the HPV vaccine anyway. The complaint alleges this showed an absolute disregard for the health and well-being of young Spanish girls.

 According to the complaint, the attitude of the Merck pharmaceutical company and Spanish health authorities (both national and regional) before, during and after the administration of Gardasil shows they care nothing about the risk to which medical consumers expose themselves whenever Gardasil is used.

 The complaint states, prior to administration, no one was concerned about possible adverse reactions to the vaccine. When adverse reactions did occur, those who experienced them were treated with contempt leaving them in a state of helplessness. There was allegedly not one single official inquiry about the girls’ post-Gardasil conditions even though they were healthy prior to being injected with Gardasil.

 An outcry from the public calling for a moratorium on the use of Gardasil until safety issues were resolved was ignored by Spanish health authorities. Injections of Gardasil continued despite the damage left behind.

 According to Attorney Don Manuel Sáez Ochoa,

 (claiming) a possible exemption arguing that they did not know at the time of processing, the dangers of the vaccine (Gardasil) is laughable……Frankly this attitude seems clearly malicious and constitutes the offense of injury as per Artile 149.1 of the Criminal Code that states: To cause another, by any means or process, the loss or worthlessness of an organ or principal member, or a sense, impotence, sterility, severe deformity, or severe somatic or mental illness, shall be punished with imprisonment of six to twelve years.
 Charges contained in the official criminal complaint

 Merck-Sanofi Pasteur, Spain’s National and Regional (La Rioja) health authorities are charged with the following:

 fraudulent marketing and/or administration of an inadequately tested vaccine;

 failure to inform the public about the potential risks of using Gardasil;

 clear infringement of the right to informed consent;

 ignoring new medical conditions in those who used Gardasil despite the similarity of their
 symptoms and the relatively short period of time between vaccine administration and the onset of symptoms;

 ignoring established and new scientific evidence illustrating the potential harmful effects of Gardasil ingredients and manufacturing methods;

 callous disregard for those suffering new medical conditions post-Gardasil;

 failure to inform the public that HPV infections are simply one of the risk factors involved in the development of cervical cancer;

 failure to inform the public that 90% of all HPV infections clear on their own without medical intervention;

 failure to inform the publlic about alternative methods of controlling cervical cancer; and
 criminal liability for the injuries resulting from the administration of Gardasil

 Even if one assumes that Merck-Sanofi Pasteur and all of the government health officials were not aware of the potential risks and lack of proven benefit of Gardasil, there has been plenty of scientific and medical evidence provided since 2007 when the vaccine was approved for use in Spain.

 Given their expertise, all of these people were aware of the fact that there are several methods to control cervical cancer that have already been proven safe and effective.

 Zuriñe was a healthy, athletic and academically gifted girl until she received the recommended three doses of Gardasil via an immunization program at her school when she was 13 years old. Three weeks later, she was admitted to the emergency room of her local hospital suffering from a multitude of symptoms including dizziness, fatigue and convulsions.

 After receiving no answers from her doctors, the conversations began to include hints of conversion disorder. Her parents decided to take her to a private specialist.

 According to this specialist, Dr. Mark Mazzuca:

 Zuriñe suffers severe cell disease, oxidative stress linked to a demineralization of her body. To put it graphically, she is an 18 year old girl locked in a cell body of a person over sixty years old.

 Zuriñe also suffers from hard infield Ortostátiaco Postural Syndrome polyneuropathy revealing a central character. It also presents as liver and bladder inflammation.

 Five years after her last Gardasil shot, Zuriñe’s life bears little resemblance to anything she once considered normal. In and out of hospitals dealing with ‘mysterious’ new medical conditions every day. No one knows how much of her normal life she will be able to regain.

 Thousands of young women around the world are finding themselves in the same position as Zuriñe. They have gone from being happy, active, and healthy to facing a multitude of autoimmune problems and neurological disorders. For them, the ‘possible’ adverse effects of Gardasil have become an all too harsh and brutal reality.

 It is time for those responsible to be held accountable for their actions. Criminal prosecution is quite possibly the only way to accomplish that goal.

 Perhaps six to twelve years in prison would remind those responsible what it means to conduct yourself in an ethical manner. Perhaps they would remember that their first duty is to maintain the public health, not destroy it.

 On July 30, the Judge decided to open criminal proceedings and investigation of the facts. The first criminal case in Spain regarding Gardasil injuries and potential criminal liability begins.
 ========================================================================
 17.8. ) India HPV, Vaccine Trials in India: Is Merck above the law?
 ========================================================================
 Source: sanevax.org/hpv-vaccine-trials-in-india-is-merck-above-the-law/

 HPV Vaccine Trials in India: Is Merck above the law?

 As a result of continued investigations regarding clinical trials involving HPV vaccines in India, more allegations of unethical conduct have been lodged against Merck. These allegations pertain to Merck’s recent trials of the new V503 HPV vaccine, a proposed nine valent HPV vaccine. A complete report of the investigation results written by Dr. Anand Rai, Kelly O’Connor, Amoli Tuli, and Anisha Bhattacharya is now a matter of public record.

 The additional allegations of multiple ethics violations were added to a currently ongoing Supreme Court Case via an affidavit added as an addendum to the brief previously prepared regarding the ’demonstration projects’ conducted by a U.S NGO PATH in India beginning in 2009. The deaths of subjects during the ’demonstration projects’ resulted in a government-ordered enquiry and suspension of all HPV vaccine trials in India pending further investigation. This suspension was effective as of April 2010 and is still in effect.

 Ultimately, the suspension and subsequent investigations allowed advocates in India to take their case all the way to the Supreme Court. The petition for the case was formally admitted by the judges on January 7, 2013. By September 2013, the court had issued notices to all participants involved while the Indian Parliament issued a scathing comment condemning all organizations involved in the so-called ’demonstration projects’ calling them a case of child abuse expressly carried out to create a market for the two companies — Merck and GlaxoSmithKline.

 According to new allegations, Merck ignored the suspension of HPV-related clinical trials and continued with a phase III trial of the yet-to-be-approved investigational HPV vaccine called V503, which theoretically adds protection against 5 types of HPV to the ones already included in their current HPV vaccine, Gardasil.
 ========================================================================
 18.) Indian Parliament Comes Down Hard on Cervical Cancer Trial
 ========================================================================
 Source: sciencemag.org/news/2013/09/indian-parliament-comes-down-hard-cervical-cancer-trial

 “It is shocking to see how an American organization used surreptitious methods to establish itself in India,” he charges. “This is an obvious case where Indians were being used as guinea pigs,” contends Samiran Nundy, a gastrointestinal expert at the Sir Ganga Ram Hospital in New Delhi and editor emeritus of the National Medical Journal of India.
 ========================================================================
 19.9.) Canada, Canadian study questioning safety of HPV vaccine retracted
 =========================================================================
 Source: news.nationalpost.com/news/canada/the-methodology-is-seriously-flawed-canadian-study-questioning-safety-of-hpv-vaccine-retracted


 ‘The methodology is seriously flawed’: Canadian study questioning safety of HPV vaccine retracted

 “A controversial paper from a University of British Columbia scientist that questioned the safety of a human papillomavirus (HPV) vaccine has been retracted.”
 'The methodology is seriously flawed': Canadian study questioning safety of HPV vaccine retracted

 A controversial paper from a University of British Columbia scientist that questioned the safety of a human…

 news.nationalpost.com

 The paper that created all the controversy was republished, and can now be read here:

 Source: link.springer.com/article/10.1007%2Fs12026-016-8826-6

 Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil

 “It appears that Gardasil via its Al [aluminum] adjuvant and HPV antigens has the ability to trigger neuroinflammation and autoimmune reactions, further leading to behavioral changes.”
 Behavioral abnormalities in female mice following administration of aluminum adjuvants and the…

 Vaccine adjuvants and vaccines may induce autoimmune and inflammatory manifestations in susceptible individuals. To…

 link.springer.com

 Toronto Star “retracts” investigative piece after extreme pressure from Pharma. You can see full
 article right here, thanks to wayback machine:

 HPV vaccine Gardasil has a dark side, Star investigation finds
 Although hundreds of thousands of girls in Canada have safely taken Gardasil, at least 60 Canadians experienced debilitating illnesses after inoculation.

 Source: web.archive.org/web/20150206100135/http://www.thestar.com/news/canada/2015/02/05/hpv-vaccine-gardasil-has-a-dark-side-star-investigation-finds.html
 ========================================================================
 20.10. Finally, the U.S.
 ========================================================================
 Source: medium.com/@jbhandley/hpv-gardasil-injury-scandals-worldwide-why-is-u-s-media-silent-parents-beware-86b416691f5b

 There hasn’t been ZERO publicity about HPV vaccine injury, it’s just been a near blackout since Katie Couric’s show in 2013. Here’s some older news:
 ========================================================================
 21.) Washington Examiner: Time for the truth about Gardasil (2010):
 =======================================================================
 Source: washingtonexaminer.com/barbara-hollingsworth-time-for-the-truth-about-gardasil/article/32562?rel=author

 Cervical cancer accounts for less than 1 percent of all cancer deaths, so it was somewhat surprising when the U.S. Food and Drug Administration fast-tracked approval of Gardasil, a Merck vaccine targeting the human papilloma virus that causes the disease, in 2006.

 As of Jan. 31, 2010, 49 unexplained deaths following Gardasil injections have been reported to the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System. By contrast, 52 deaths are attributed to unintended acceleration in Toyotas, which triggered a $2 billion recall.

 No recall for Gardasil, which is required for sixth-grade girls in D.C., Maryland, Virginia, and many other states. Parents can opt out, but few know the true risks.

 That was the certainly the case for Mary Davison of Frederick, Md., whose three daughters had the second of a three-shot vaccination regimen in January 2008. Her two younger girls had no reactions, but 20-year-old Mary Katherine felt sick and dizzy.
 ========================================================================
 22.) New Concerns about the Human Papillomavirus Vaccine
 ========================================================================
 Source: washingtonexaminer.com/barbara-hollingsworth-time-for-the-truth-about-gardasil/article/32562?rel=author


 The American College of Pediatricians (The College) is committed to the health and well-being of children, including prevention of disease by vaccines. It has recently come to the attention of the College that one of the recommended vaccines could possibly be associated with the very rare but serious condition of premature ovarian failure (POF), also known as premature menopause. There have been two case report series (3 cases each) published since 2013 in which post-menarcheal adolescent girls developed laboratory documented POF within weeks to several years of receiving Gardasil, a four-strain human papillomavirus vaccine (HPV4).1,2 Adverse events that occur after vaccines are frequently not caused by the vaccine and there has not been a noticeable rise in POF cases in the last 9 years since HPV4 vaccine has been widely used.
 Nevertheless there are legitimate concerns that should be addressed: (1) long-term ovarian function was not assessed in either the original rat safety studies3,4 or in the human vaccine trials, (2) most primary care physicians are probably unaware of a possible association between HPV4 and POF and may not consider reporting POF cases or prolonged amenorrhea (missing menstrual periods) to the Vaccine Adverse Event Reporting System (VAERS), (3) potential mechanisms of action have been postulated based on autoimmune associations with the aluminum adjuvant used1 and previously documented ovarian toxicity in rats from another component, polysorbate 80,2 and (4) since licensure of Gardasil® in 2006, there have been about 213 VAERS reports (per the publicly available CDC WONDER VAERS database) involving amenorrhea, POF or premature menopause, 88% of which have been associated with Gardasil.5 The two- strain HPV2, CervarixTM, was licensed late in 2009 and accounts for 4.7 % of VAERS amenorrhea reports since 2006, and 8.5% of those reports from February 2010 through May 2015. This compares to the pre-HPV vaccine period from 1990 to 2006 during which no cases of POF or premature menopause and 32 cases of amenorrhea were reported to VAERS.
 

========================================================================

 

  Produced by Dr. Jose Lapenta R. Dermatologist

                 Maracay Estado Aragua Venezuela 2.017  

           Telf: 02432327287-02432328571   

 

          Follow @dermagicexpress

Si Te ha gustado, Compartelo

• Facebook
• X
• Pinterest
• Whatsapp
• Telegram